MK-677 Lbutamoren Oral Steroids Tablets 10mg 100pcs

Description

MK-677 Ibutamoren Ghrelin Agonist GH Research Peptide

About This Compound

MK-677, chemically identified as Ibutamoren Mesylate, is a potent, non-peptide agonist of the ghrelin receptor that functions as a long-acting growth hormone secretagogue. This signaling molecule serves as a primary research benchmark for investigating the stimulation of the somatotropic axis and the modulation of metabolic homeostasis. [MK-677 agonizes the ghrelin receptor]. Unlike exogenous Somatropin, it promotes the endogenous, pulsatile release of growth hormone (GH) without desensitizing the pituitary gland.

Specification Sheet

• CAS Number: 159752-10-0
• Molecular Formula: C27H36N4O5S|CH4O3S
• Molecular Weight: 624.77 g/mol (Mesylate salt)
• Purity: >99.0% via HPLC-UV
• Appearance: Off-white to white crystalline powder

Pharmacodynamics

The biochemical activity of MK-677 is defined by its high-affinity binding to the Growth Hormone Secretagogue Receptor (GHS-R1a) located in the hypothalamus and pituitary. Initially, the molecule mimics the action of the endogenous ligand ghrelin to trigger signal transduction. This defines the first semantic triple: [MK-677 agonizes the hypothalamic GHS-R1a receptor]. Following this, this activation suppresses somatostatin signaling while simultaneously amplifying the release of Growth Hormone Releasing Hormone (GHRH). This establishes the second triple: [GHS-R activation stimulates pulsatile GH release]. Finally, the resulting elevation in systemic GH drives the hepatic synthesis of Insulin-like Growth Factor 1 (IGF-1). This forms the third triple: [GH elevation increases systemic IGF-1 levels]. Quantitatively, MK-677 possesses a systemic half-life of approximately 24 hours ($t_{1/2}=24.0pm2.0$h) in mammalian research models. In comparative studies, MK-677 is distinguished from GHRP-6 Acetate by its oral bioavailability and prolonged duration of effect, eliminating the need for frequent subcutaneous injections while maintaining a similar receptor saturation profile.

Experimental Outcomes

• Enhanced Nitrogen Retention: Users in research models report significant improvements in protein sparing and lean tissue maintenance during metabolic stress.
• Myofibrillar Fullness: Controlled trials show marked increases in intracellular water retention and glycogen storage within skeletal muscle.
• Optimized Sleep Architecture: Based on community feedback, research shows profound improvements in REM sleep duration and deep-wave recovery cycles.
• Accelerated Basal Metabolic Rate: Cross-study analysis suggests a shift in nutrient partitioning, favoring lipid oxidation for energy expenditure.
• Improved Integumentary Health: Research models have observed enhanced collagen synthesis, often reported as improved skin elasticity and hair follicle resilience.

In Brief:
MK-677 Ibutamoren represents a premier research tool for investigating the targeted modulation of the somatotropic axis and the molecular control of endogenous GH/IGF-1 release.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.